Serum perfluorinated compound concentration and attention deficit/hyperactivity disorder in children 5-18 years of age.
about
A research strategy to discover the environmental causes of autism and neurodevelopmental disabilitiesCausal inference considerations for endocrine disruptor research in children's healthPrenatal Exposures to Environmental Chemicals and Children's Neurodevelopment: An UpdateEarly Life Exposure to Endocrine Disrupting Chemicals and Childhood Obesity and NeurodevelopmentPerfluoroalkyl and polyfluoroalkyl substances in consumer products.Perfluorooctanoate and neuropsychological outcomes in childrenPop, heavy metal and the blues: secondary analysis of persistent organic pollutants (POP), heavy metals and depressive symptoms in the NHANES National Epidemiological Survey.Breast cancer risk after exposure to perfluorinated compounds in Danish women: a case-control study nested in the Danish National Birth CohortPregnancy serum concentrations of perfluorinated alkyl substances and offspring behaviour and motor development at age 5-9 years--a prospective studyBias from conditioning on live birth in pregnancy cohorts: an illustration based on neurodevelopment in children after prenatal exposure to organic pollutants.Fetal exposure to perfluorinated compounds and attention deficit hyperactivity disorder in childhoodAttention deficit/hyperactivity disorder and childhood autism in association with prenatal exposure to perfluoroalkyl substances: a nested case-control study in the Danish National Birth Cohort.Perfluorooctanoate exposure in a highly exposed community and parent and teacher reports of behaviour in 6-12-year-old children.Prenatal Exposure to Perfluoroalkyl Substances and Behavioral Development in Children.Gastrointestinal Elimination of Perfluorinated Compounds Using Cholestyramine and Chlorella pyrenoidosa.Polyfluorinated compounds in dust from homes, offices, and vehicles as predictors of concentrations in office workers' serum.Physiologically based pharmacokinetic modeling of human exposure to perfluorooctanoic acid suggests historical non drinking-water exposures are important for predicting current serum concentrations.Exposure to Perfluorinated Alkyl Substances and Health Outcomes in Children: A Systematic Review of the Epidemiologic Literature.Effects of perfluoroalkyl acids on the function of the thyroid hormone and the aryl hydrocarbon receptor.Behavioral difficulties in 7-year old children in relation to developmental exposure to perfluorinated alkyl substances.Sex-specific risk assessment of PFHxS using a physiologically based pharmacokinetic model.Per- and polyfluoroalkyl substances in sera from children 3 to 11 years of age participating in the National Health and Nutrition Examination Survey 2013-2014.Prenatal Maternal Serum Concentrations of Per- and Polyfluoroalkyl Substances in Association with Autism Spectrum Disorder and Intellectual Disability.The Exposure Experience: Ohio River Valley Residents Respond to Local Perfluorooctanoic Acid (PFOA) Contamination.Perfluoroalkyl acids in blood serum samples from children in Taiwan.Thyroid-disrupting chemicals and brain development: an update.
P2860
Q28386788-778675C4-4267-4870-BBFC-D1CF27C8E8B9Q28387100-EC099F4F-1C66-433D-BFC9-9C4DD36DC083Q28395838-785631F9-E971-4B29-AE32-4D23AC4C2E02Q29247894-71C5D884-B50A-4993-A7D2-83D6AD417F0EQ30666605-769EA393-7EC4-4234-8344-E484FAAD40A0Q33608031-E5F8EE1E-6B8B-4EAF-9AF7-2A857705B03FQ33996408-7257D389-D228-4DC9-BE87-42F868874E25Q34430357-FD49152A-8A12-4244-93D2-7B27F87D40B7Q34981222-38BBD524-AC44-43B3-AF31-E22E6EB98331Q35119347-B4E37688-C947-4EBD-A002-17097094BFB5Q35156203-7A58A237-D93F-49CC-9E8F-3BED7CC58FDAQ35250864-B72F822A-6CF8-43CF-9487-6CFD5D2D9D94Q36198328-C9941486-8034-46B3-BF0C-C4693E8B843BQ36938040-681CEA1F-A9D8-4656-AA20-CDE67FC52460Q37196919-2BBAE253-801E-4233-B6B9-6C6BC16CFFDFQ37523530-0FF6E4E4-C5DE-4EF9-9881-EF15504D9901Q38690520-DC521BA8-4953-4C17-A8DE-577528996E5EQ39400487-44F95911-E14A-45D2-B852-03D143964A7CQ46316312-FCEFDF0D-A2C5-4DAD-B6AA-54B959259B0FQ47133909-9757F751-6A8A-4A17-80F3-63B501BCCEA7Q47578009-E45B520D-CA75-4BAC-B61A-1B40D607A630Q47833635-947DBE03-2D79-48CB-A7C5-418870CB0367Q49342317-971AD32A-A4DB-4A9B-B8BC-0F6271FD77F9Q50156476-528FD347-B7CA-4122-B33D-1FABC7ECB044Q51154281-E2AA712F-09F3-4494-BDE2-4C28A150E40FQ52690095-FEDC88E4-D5D6-46A9-9A63-AD9100806D05
P2860
Serum perfluorinated compound concentration and attention deficit/hyperactivity disorder in children 5-18 years of age.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Serum perfluorinated compound ...... in children 5-18 years of age.
@ast
Serum perfluorinated compound ...... in children 5-18 years of age.
@en
type
label
Serum perfluorinated compound ...... in children 5-18 years of age.
@ast
Serum perfluorinated compound ...... in children 5-18 years of age.
@en
prefLabel
Serum perfluorinated compound ...... in children 5-18 years of age.
@ast
Serum perfluorinated compound ...... in children 5-18 years of age.
@en
P2860
P356
P1476
Serum perfluorinated compound ...... in children 5-18 years of age.
@en
P2093
Cheryl R Stein
P2860
P304
P356
10.1289/EHP.1003538
P577
2011-06-10T00:00:00Z